Towards a new galenic formulation;Vers une nouvelle galénique

Biofutur

Volumn , Issue 240, 2004, Pages 22-25

  Vauthier, Christine ^b   Bochot, Amélie ^b   Couvreur, Patrick ^a  

^a UNIV PARIS SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; DOXORUBICIN; LIPOSOME; MACROGOL; NANOPARTICLE;

ARTICLE; BIOTECHNOLOGY; CARDIOTOXICITY; COMMERCIAL PHENOMENA; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG INDUSTRY; DRUG RESEARCH; HUMAN; TOXICITY;

EID: 0942266204     PISSN: 02943506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Le Hir, Abrégé de Pharmacie Galénique, Masson, Paris
2. R. Langer (2003) Pour la Science 309, 52-7
3. P. Couvreur, Nanotechnologies et nouveaux médicaments, Université de Tous les Savoirs, Éditions Odile Jacob
4. A.A. Gabizon (2001) Clin. Cancer Res 7, 223-5
5. G. Barratt (2003) Cell. Mol. Life Sci., 60, 21-37
6. B. Ceh et al. (1997) Adv. Drug Deliv. Rev. 24, 165-77
7. P. Couvreur et al. (2002) Crit. Rev. Therap. Drug Carrier Systems 19, 99-134
8. C. Vauthier, E. Fattal, D. Labarre, From polymer chemistry and physicochemistry to nanoparticular drug carrier design and applications, In «Biomaterial Handbook-Advanced Applications of Basic Sciences and Bioengineering», D.L. Wise Editor, Marcel Dekker, Inc., New York, Sous presse
9. A. Bochot et al. (2002) Pharma Pratiques. 12 (1), 42-9
10. P. Legrand et al. (1999) STP Pharma Science 1000 (9), 411-8
11. F. De Jaeghere., E. Doelker, R. Gurny. Nanoparticles. In Encyclopedia of controlled drug delivery. J. Wiley and Son, New York, 1999, 641-64
12. E. Dellacherie et al. (2001) Médecine/Sciences 17, 619-26
13. S.L. Croft et al. (2003) Trends in Parasitology 19, 502-8
14. I. Brigger et al. (2002) Adv. Drug Deliv. Rev. 54, 631-51
15. I. Brigger et al. (2002) J. Pharmacol. Exp. Ther. 303, 928-36
16. J. Sudimack, R.J. Lee (2000) Adv. Drug Deliv. Rev. 41, 147-62
17. C. Vauthier et al. (2003) Adv. Drug Deliv. Rev. 55, 519-48
18. F. Muggia, A. Hamilton (2001) Eur. J. Cancer 37, S15-S18.
19. A. Bochot et al. (2000) Progress in Retinal and Eye Research 19, 131-47
20. R.S. Geary et al. (2002) Glin Pharmacokinet. 41, 255-60